Molecular mechanism of glycosylated IL-1RII counteraction with IL-1RI in regulation of the immune response

被引:0
作者
Khameneh, Narges Jamshidi [1 ]
Irani, Maryam Azimzadeh [2 ]
Ejtehadi, Mohammad Reza [1 ]
机构
[1] Sharif Univ Technol, Dept Phys, Tehran, Iran
[2] Shahid Beheshti Univ, Fac Life Sci & Biotechnol, Tehran, Iran
关键词
Glycosylation; immune response; IL-1RII; molecular dynamics simulation; CRYSTAL-STRUCTURE; BLOCKING INTERLEUKIN-1; TREATING INFLAMMATION; N-GLYCANS; RECEPTOR; PROTEIN; FAMILY; SUPERFAMILY; IL-1-BETA;
D O I
10.1080/08927022.2023.2243339
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Interleukin-1 Receptor Type II (IL-1RII) is the decoy receptor of IL-1 cytokines. It down-regulates the immune signalling pathways. There is a competitive behaviour between the IL-1RII and IL-1RI, which is the signalling receptor of the IL-1Rs family. By adopting similarities in structure and specific shared ligands, the two receptors are competing regulators of the immune response. Conformational changes of IL-1RII is a crucial factor in its ligand binding and activation. In addition, dynamics and functionality of the receptor are known to be regulated by glycosylation. Herein, all-atom Molecular Dynamics (MD) simulations were carried out to investigate the dynamics of the apo and cytokine-bound IL-1RII upon full glycosylation. Simulations showed that the IL-1RII presents two extended/active and compact/inactive conformations. Glycosylation maintains the conformation in the extended/active state. Furthermore, It was shown that IL-1 cytokine binding to IL-1RII contributes to stabilisation of the receptor. Comparison of IL-1RI and IL-1RII interaction with IL-1 & beta; at the equilibrium condition predicted that glycosylation could increase the binding possibility of IL-1RII towards its ligand. That supports preservation of the active/extended conformation by glycosylation as observed in MD simulations.
引用
收藏
页码:1491 / 1501
页数:11
相关论文
共 42 条
  • [1] Interleukin-1 and neuronal injury
    Allan, SM
    Tyrrell, PJ
    Rothwell, NJ
    [J]. NATURE REVIEWS IMMUNOLOGY, 2005, 5 (08) : 629 - 640
  • [2] Glycan-mediated functional assembly of IL-1RI: structural insights into completion of the current description for immune response
    Azimzadeh Irani, Maryam
    Ejtehadi, Mohammad Reza
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (06) : 2575 - 2585
  • [3] The family of the interleukin-1 receptors
    Boraschi, Diana
    Italiani, Paola
    Weil, Sabrina
    Martin, Michael U.
    [J]. IMMUNOLOGICAL REVIEWS, 2018, 281 (01) : 197 - 232
  • [4] Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet β-cell de-differentiation
    Burke, Susan J.
    Batdorf, Heidi M.
    Burk, David H.
    Martin, Thomas M.
    Mendoza, Tamra
    Stadler, Krisztian
    Alami, Wateen
    Karlstad, Michael D.
    Robson, Matthew J.
    Blakely, Randy D.
    Mynatt, Randall L.
    Collier, J. Jason
    [J]. MOLECULAR METABOLISM, 2018, 14 : 95 - 107
  • [5] MOLECULAR-CLONING OF THE INTERLEUKIN-1-BETA CONVERTING ENZYME
    CERRETTI, DP
    KOZLOSKY, CJ
    MOSLEY, B
    NELSON, N
    VANNESS, K
    GREENSTREET, TA
    MARCH, CJ
    KRONHEIM, SR
    DRUCK, T
    CANNIZZARO, LA
    HUEBNER, K
    BLACK, RA
    [J]. SCIENCE, 1992, 256 (5053) : 97 - 100
  • [6] THE TYPE-II DECOY RECEPTOR - A NOVEL REGULATORY PATHWAY FOR INTERLEUKIN-1
    COLOTTA, F
    DOWER, SK
    SIMS, JE
    MANTOVANI, A
    [J]. IMMUNOLOGY TODAY, 1994, 15 (12): : 562 - 566
  • [7] Dinarello C.A., 2019, Textbook of Autoinflammation, P711, DOI DOI 10.1007/978-3-319-98605-0_39
  • [8] Overview of the IL-1 family in innate inflammation and acquired immunity
    Dinarello, Charles A.
    [J]. IMMUNOLOGICAL REVIEWS, 2018, 281 (01) : 8 - 27
  • [9] Treating inflammation by blocking interleukin-1 in humans
    Dinarello, Charles A.
    van der Meer, Jos W. M.
    [J]. SEMINARS IN IMMUNOLOGY, 2013, 25 (06) : 469 - 484
  • [10] Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
    Dinarello, Charles A.
    Simon, Anna
    van der Meer, Jos W. M.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (08) : 633 - 652